Harvard Stem Cell Institute (HSCI) scientists have successfully grown the cells that line the blood vessels—called vascular endothelial cells—from human induced pluripotent stem cells (iPSCs), revealing new details about how these cells function.
Cook Medical is shipping its Zilver PTX drug-eluting peripheral stent to medical centres in the USA, Japan, Europe and other major markets again. The shipments follow a brief period of unavailability due to a voluntary recall by Cook related to an issue with the stent’s delivery catheter that has been resolved.
Peter Goverde who presented the Belgian registry results at EuroPCR 2013 in Paris, France (21–24 May), said that stenting of the superficial femoral artery with the biodegradable Remedy stent was safe and feasible.
Covidien (Mansfield, MA) has commenced enrollment in the ILLUMENATE Pivotal and ILLUMENATE PK (Pharmacokinetics) trials, which are components of the global ILLUMENATE clinical trial program. This program is a series of studies on the safety and effectiveness of Covidien’s Stellarex drug-coated angioplasty balloon for the treatment of patients with peripheral arterial disease (PAD).
One-year results of the VIASTAR trial published online in the Journal of the American College of Cardiology suggest that a heparin-bonded covered stent may be superior to bare metal stents in the treatment of long femoropopliteal artery disease.
Video
Medtronic, Inc. (Minneapolis, MN) announced that the US Food and Drug Administration (FDA) has approved the company’s Complete SE self-expanding vascular stent for use in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
CID announced on 18 July 2013 the CE mark of its drug-eluting stent for the treatment of below-the-knee lesions: the Cre8 BTK device. According to CID, the Cre8 BTK polymer-free device embodies the most advanced drug-eluting stent technologies to treat peripheral vascular disease. “Its unique distinctive features—Abluminal Reservoir Technology, Amphilimus formulation and Bio Inducer Surface – make Cre8 the only very effective polymer-free drug-eluting stent available today,” the company claimed.
Vascular specialists at the 2nd Military Medical University-Shanghai Hospital, the 2nd Affiliated Hospital of Harbin Medical University, Jiangsu Province People’s Hospital and Peking University People’s Hospital, China, recently performed the initial implants of a branched stent graft system (Microport).
Endologix, Inc. (Irvine, CA) announced it has completed an initial evaluation of its Ventana clinical trial in the United States that was suspended earlier this year.
Hansen Medical, and Royal Philips have announced that they have reached an important milestone in their long-term collaboration by securing certified compatibility between Hansen Medical’s Magellan Robotic System and Philips’ Allura interventional X-ray systems. According to a company release, article 12 compatibility covers specific technical and service requirements, and means that the Magellan Robotic System is compatible with Philips’ Allura live image-guidance systems when used according to instructions.
Cook Medical (Bloomington, IN) announced that 83.2% of patients with femoropopliteal lesions who were treated with the company’s Zilver PTX self-expanding paclitaxel-coated nitinol stent did not require revascularization at 4 years. This freedom from target lesion revascularization (TLR) rate compares favorably to the 69.4% freedom from TLR rate at 4 years in patients treated with percutaneous transluminal angioplasty (PTA) and a bare metal stent.
The phase III AMPLIFY results, published in New England Journal of Medicine and presented as a late-breaking trial at the Congress of the International Society on Thrombosis and Haemostasis (29 June–4 July 2013, Amsterdam, The Netherlands) showed that apixaban achieved its primary endpoint of noninferiority to the current standard of care.
Aptus Endosystems, a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), has announced that its ANCHOR post-market registry enrolment has surpassed its key milestone of 250 patients.
The results of an investigation to evaluate the predictive value of magnetic resonance imaging (MRI) measures of aortic atherosclerosis for future cardiac events have been published in the June edition of Radiology.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos